Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Health Canada: Changing Up the Sample Game

Jun 4, 2020

Health Canada has recently released updates applicable to Natural Health Products and Non-Prescription Drug Regulations. Beginning July 1st, associated industries will be able to distribute certain types of these products as free samples. Distribution of NHP and...

COVID-19 Impacts on Biomedical Technology Industry

Jun 3, 2020

We have touched on many subjects regarding the COVID-19 pandemic, such as cosmetics, sanitization products, and updates to international regulations. However, there is one topic we have yet to discuss that has experienced a great impact during this difficult time, the...

A Shift in Cosmetic Marketing Towards Mental Health

Jun 2, 2020

The coronavirus pandemic forced the cosmetic market to shift their marketing strategies to embrace the new normal. As people were encouraged to work from home and shift their social activities to an online format, the cosmetic industry shifted their advertisements to...

Revisions to Health Canada’s COVID-19 Hand Sanitizer and Disinfectant Interim Policies

May 20, 2020

In March, Health Canada put in place an interim policy for their regulations for hand sanitizers and disinfectant products. This was in response to the high supply and demand for these types of products due to the COVID-19 pandemic, which caused a 735% increase in...

Biotechnology: Production of Natural and Sustainable Ingredients

May 12, 2020

Consumers are more enticed to purchase a cosmetic or personal care product that displays the word ‘natural’ or ‘organic’, or a product that is known to contain ingredients from a sustainable source. This growing desire from...

Health Canada: Mandatory Use of New Regulatory Enrolment Process for Drug Submissions

May 12, 2020

Recently, Health Canada announced that the Regulatory Enrolment Process (REP) will be mandatory to use as of October 1, 2020. The Health Products and Food Branch (HPFB) will be implementing this single window for transmission of regulatory transactions in electronic...

Cannabis in Cosmetics; Where Are We Now

Apr 28, 2020

A couple of years ago the world began legalizing recreational cannabis, bringing it into the cosmetic industry. Since then, it has been reported that the cosmetic CBD market has a net worth of 710 million US dollars and is projected to have a net worth of 959 million...

Health Canada Guidance Document on Interim Expedited Hand Sanitizer Approval Process

Apr 16, 2020

Health Canada has released a guide document pertaining to the temporary expedited process for the production and distribution of hand sanitizers in Canada. The document highlights acceptable quality grades and medicinal ingredient concentrations, formulation...

A Summary of International Efforts in Minimizing the Spread of COVID-19

Apr 3, 2020

Recently, information has been provided regarding updates that Health Canada and the U.S. FDA have done in order to aid in the battle against COVID-19. However, other countries have also taken drastic measures to assist with reducing the spread of COVID-19. The...

Health Canada Extension on Nitrosamine Risk Assessments

Apr 3, 2020

Earlier this year, information about new regulations and requirements put in place by Health Canada for product’s containing nitrosamine impurities was released. These regulations are applicable to prescription and non-prescription pharmaceuticals containing...

« Older Entries

Next Entries »

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us